Retinal Degenerations Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Retinal Degeneration / Degeneration retinal

IndicationStatusPhase
DBCOND0041282 (Retinal Degenerations)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02348359X-82 to Treat Age-related Macular DegenerationTreatment